ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Sodium Hydroxide → 1-{2-[3-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-thiadiazol-3-yl)-2-ethylphenyl]ethyl}-L-proline

HRID 1942754
ノート
印刷プレビュー

反応式

HRID 1942754 の反応式
[Cl:1][C:2]1[CH:3]=[C:4]([C:12]2[S:16][N:15]=[C:14]([C:17]3[C:18]([CH2:26][CH3:27])=[C:19]([CH2:23][CH:24]=O)[CH:20]=[CH:21][CH:22]=3)[N:13]=2)[CH:5]=[CH:6][C:7]=1[O:8][CH:9]([CH3:11])[CH3:10].C([O-])(=O)C.[Na+].Cl.[NH:34]1[CH2:42][CH2:41][CH2:40][C@H:35]1[C:36]([O:38]C)=[O:37].C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].[OH-].[Na+]>ClCCl.C(O)(C)C.O>[Cl:1][C:2]1[CH:3]=[C:4]([C:12]2[S:16][N:15]=[C:14]([C:17]3[C:18]([CH2:26][CH3:27])=[C:19]([CH2:23][CH2:24][N:34]4[CH2:42][CH2:41][CH2:40][C@H:35]4[C:36]([OH:38])=[O:37])[CH:20]=[CH:21][CH:22]=3)[N:13]=2)[CH:5]=[CH:6][C:7]=1[O:8][CH:9]([CH3:11])[CH3:10]
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 14798Sodium HydroxideHCID 517045Sodium AcetateHCID 2733200methyl L-prolinate hydrochlorideHCID 5049666Sodium triacetoxyborohydrideHCID 58494142[3-(5-{3-Chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-thiadiazol-3-yl)-2-ethylphenyl]acetaldehyde

生成物 1

HCID 54578029
1-{2-[3-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-thiadiazol-3-yl)-2-ethylphenyl]ethyl}-L-proline
収率 40.9%

試薬・触媒・溶媒 2

HCID 6344Dichloromethane溶媒HCID 21889133Propan-2-ol--water (1/1)溶媒

実験手順

To a solution of [3-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-thiadiazol-3-yl)-2-ethylphenyl]acetaldehyde (D52) (110 mg, 0.274 mmol) in Dichloromethane (DCM) (10 mL) was added sodium acetate (33.8 mg, 0.412 mmol) and hydrogen chloride-methyl L-prolinate (1:1) (68.2 mg, 0.412 mmol). After 5 minutes, sodium triacetoxyborohydride (87 mg, 0.412 mmol) was added and the reaction solution was stirred at room temperature overnight. The solvent was removed in vacuo and the residue was hydrolized by NaOH (2.74 mL, 1.372 mmol) in isopropanol/water (10 mL, 1:1). The residue was purified by Mass Directed AutoPrep to afford 1-{2-[3-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-thiadiazol-3-yl)-2-ethylphenyl]ethyl}-L-proline (E65) (56 mg) as a TFA salt.

後処理

  1. customThe solvent was removed in vacuo
  2. customThe residue was purified by Mass Directed AutoPrep

出典と根拠

ORDレコード
ord-ed665942fabc41079a24dd7a3ae2ad6c
出典データセット
uspto-grants-2013_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08389508B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート